Infection
Rachel C. Wolfe, PharmD,
Barnes Jewish Hospital
Disclosure(s): Heron Therapeutics: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
The topic will review antimicrobial susceptibility testing, interpretation of MICs, and how antibiotic breakpoints are determined for each bug-drug combination. How the pharmacokinetic and pharmacodynamic principles come into play when selecting antibiotics and dosing will also be briefly discussed.